Lmr Partners LLP Kymera Therapeutics, Inc. Put Options Transaction History
Lmr Partners LLP
- $9.66 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding KYMR
# of Institutions
184Shares Held
66MCall Options Held
44.5KPut Options Held
38.5K-
Price T Rowe Associates Inc Baltimore, MD6.87MShares$253 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$221 Million2.67% of portfolio
-
Wellington Management Group LLP Boston, MA5.31MShares$196 Million0.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$190 Million7.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.15MShares$190 Million3.02% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.02B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...